To sum up, this study was the first to suggest that the inhibition of malignant biological behavior and the promotion of glycolysis by FUBP1 in colon cancer cells was related to c-Myc, which would provide a reference for determining the potential mechanism of FUBP1 in the development of colon cancer. Here, MYC is linked to colonic neoplasm.